Macular Degeneration
Conditions
Keywords
Non-exudative age-related macular degeneration
Brief summary
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
Interventions
None listed
Sponsors
ORA, Inc.
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Subjects in good health aged 20-29 or 60-90 years (normal cohorts) * Subjects with early non-exudative age-related macular degeneration (AMD cohort)
Exclusion criteria
* Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study
Countries
United States
Outcome results
None listed